{"count": 4, "results": [{"_id": "36280839", "pmid": 36280839, "pmcid": "PMC9594974", "title": "Efficacy of metformin therapy in patients with cancer: a meta-analysis of 22 randomised controlled trials", "journal": "BMC Med", "authors": ["Wen J", "Yi Z", "Chen Y", "Huang J", "Mao X", "Zhang L", "Zeng Y", "Cheng Q", "Ye W", "Liu Z", "Liu F", "Liu J"], "date": "2022-10-24T00:00:00Z", "doi": "10.1186/s12916-022-02599-4", "meta_date_publication": "2022 Oct 24", "meta_volume": "20", "meta_issue": "1", "meta_pages": "402", "score": 50284.566, "text_hl": "For @<m>DISEASE_Digestive_System_Neoplasms</m> @DISEASE_MESH:D004067 @@@digestive system cancers@@@, @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ use showed significantly worse PFS (HR 1.45, 95% CI 1.03-2.04) (Fig. 3). ", "citations": {"NLM": "Wen J, Yi Z, Chen Y, Huang J, Mao X, Zhang L, Zeng Y, Cheng Q, Ye W, Liu Z, Liu F, Liu J. Efficacy of metformin therapy in patients with cancer: a meta-analysis of 22 randomised controlled trials BMC Med. 2022 Oct 24;20(1):402. PMID: 36280839", "BibTeX": "@article{36280839, title={Efficacy of metformin therapy in patients with cancer: a meta-analysis of 22 randomised controlled trials}, author={Wen J and Yi Z and Chen Y and Huang J and Mao X and Zhang L and Zeng Y and Cheng Q and Ye W and Liu Z and Liu F and Liu J}, journal={BMC Med}, volume={20}, number={1}, pages={402}}"}}, {"_id": "34007128", "pmid": 34007128, "pmcid": "PMC8108031", "title": "Repurposing metformin for the treatment of gastrointestinal cancer", "journal": "World J Gastroenterol", "authors": ["Cunha Júnior AD", "Bragagnoli AC", "Costa FO", "Carvalheira JBC"], "date": "2021-05-07T00:00:00Z", "doi": "10.3748/wjg.v27.i17.1883", "meta_date_publication": "2021 May 7", "meta_volume": "27", "meta_issue": "17", "meta_pages": "1883-1904", "score": 50268.734, "text_hl": "Studies in vitro and in vivo models have demonstrated the potential of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ as a chemo- and radiosensitizer, besides its chemopreventive and direct therapeutic activity in @<m>DISEASE_Digestive_System_Neoplasms</m> @DISEASE_MESH:D004067 @@@digestive system (DS) tumors@@@. ", "citations": {"NLM": "Cunha Júnior AD, Bragagnoli AC, Costa FO, Carvalheira JBC. Repurposing metformin for the treatment of gastrointestinal cancer World J Gastroenterol. 2021 May 7;27(17):1883-1904. PMID: 34007128", "BibTeX": "@article{34007128, title={Repurposing metformin for the treatment of gastrointestinal cancer}, author={Cunha Júnior AD and Bragagnoli AC and Costa FO and Carvalheira JBC}, journal={World J Gastroenterol}, volume={27}, number={17}, pages={1883-1904}}"}}, {"_id": "39773528", "pmid": 39773528, "title": "Metformin and the risk of malignant tumors of digestive system: a mendelian randomization study.", "journal": "Diabetol Metab Syndr", "authors": ["Liu P", "Xiao J", "Xiao J", "Zhou J"], "date": "2025-01-07T00:00:00Z", "doi": "10.1186/s13098-024-01573-9", "meta_date_publication": "2025 Jan 7", "meta_volume": "17", "meta_issue": "1", "meta_pages": "6", "score": 50262.69, "text_hl": "BACKGROUND: Observational studies suggest that @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ may reduce the risk of @<m>DISEASE_Digestive_System_Neoplasms</m> @DISEASE_MESH:D004067 @@@malignant tumors of the digestive system@@@ (MTDS), but these findings are often confounded by bias and unmeasured variables. ", "citations": {"NLM": "Liu P, Xiao J, Xiao J, Zhou J. Metformin and the risk of malignant tumors of digestive system: a mendelian randomization study. Diabetol Metab Syndr. 2025 Jan 7;17(1):6. PMID: 39773528", "BibTeX": "@article{39773528, title={Metformin and the risk of malignant tumors of digestive system: a mendelian randomization study.}, author={Liu P and Xiao J and Xiao J and Zhou J}, journal={Diabetol Metab Syndr}, volume={17}, number={1}, pages={6}}"}}, {"_id": "27118574", "pmid": 27118574, "title": "Combinational strategies of metformin and chemotherapy in cancers.", "journal": "Cancer Chemother Pharmacol", "authors": ["Zhang HH", "Guo XL"], "date": "2016-07-01T00:00:00Z", "doi": "10.1007/s00280-016-3037-3", "meta_date_publication": "2016 Jul", "meta_volume": "78", "meta_issue": "1", "meta_pages": "13-26", "score": 50062.08, "text_hl": "In this review, we summarized the molecular mechanisms underlying anticancer effects of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@, which included @GENE_INS @GENE_3630 @@@insulin@@@- and @GENE_PRKAA2 @GENE_5563 @@@AMPK@@@-dependent effects, selectively targeting @DISEASE_Neoplasms @DISEASE_MESH:D009369 @@@cancer@@@ stem cells, reversing multidrug resistance, inhibition of the @DISEASE_Neoplasm_Metastasis @DISEASE_MESH:D009362 @@@tumor metastasis@@@ and described the antineoplastic effects of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ combined with chemotherapeutic agents in @<m>DISEASE_Digestive_System_Neoplasms</m> @DISEASE_MESH:D004067 @@@digestive system cancers@@@ (@DISEASE_Colorectal_Neoplasms @DISEASE_MESH:D015179 @@@colorectal, gastric, hepatic and pancreatic cancer@@@), @DISEASE_Neoplasms @DISEASE_MESH:D009369 @@@reproductive system cancers@@@ (@DISEASE_Endometrial_Hyperplasia @DISEASE_MESH:D004714 @@@ovarian and endometrial cancer@@@), @DISEASE_Prostatic_Neoplasms @DISEASE_MESH:D011471 @@@prostate cancer@@@, @DISEASE_Breast_Neoplasms @DISEASE_MESH:D001943 @@@breast cancer@@@, @DISEASE_Lung_Neoplasms @DISEASE_MESH:D008175 @@@lung cancer@@@, etc. ", "citations": {"NLM": "Zhang HH, Guo XL. Combinational strategies of metformin and chemotherapy in cancers. Cancer Chemother Pharmacol. 2016 Jul;78(1):13-26. PMID: 27118574", "BibTeX": "@article{27118574, title={Combinational strategies of metformin and chemotherapy in cancers.}, author={Zhang HH and Guo XL}, journal={Cancer Chemother Pharmacol}, volume={78}, number={1}, pages={13-26}}"}}]}